XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Statements Of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Total
Balance, beginning of period at Dec. 31, 2022 $ 1,298,740 $ 323,288 $ (105,319) $ 1,516,709
Balance, beginning of period (in shares) at Dec. 31, 2022 151,935      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income   1,935   1,935
Foreign currency translation adjustments     20,717 20,717
Repurchases of common stock $ (10,129)     (10,129)
Repurchases of common stock (in shares) (1,410)      
Activity in company stock plans, net and other $ (296)     (296)
Activity in company stock plans, net and other (in shares) 285      
Share-based compensation $ 2,992     2,992
Balance, end of period at Jun. 30, 2023 $ 1,291,307 325,223 (84,602) 1,531,928
Balance, end of period (in shares) at Jun. 30, 2023 150,810      
Balance, beginning of period at Mar. 31, 2023 $ 1,294,484 318,123 (96,887) 1,515,720
Balance, beginning of period (in shares) at Mar. 31, 2023 151,494      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income   7,100   7,100
Foreign currency translation adjustments     12,285 12,285
Repurchases of common stock $ (5,123)     (5,123)
Repurchases of common stock (in shares) (750)      
Activity in company stock plans, net and other $ 446     446
Activity in company stock plans, net and other (in shares) 66      
Share-based compensation $ 1,500     1,500
Balance, end of period at Jun. 30, 2023 $ 1,291,307 325,223 (84,602) 1,531,928
Balance, end of period (in shares) at Jun. 30, 2023 150,810      
Balance, beginning of period at Dec. 31, 2023 $ 1,271,565 312,450 (83,015) 1,501,000
Balance, beginning of period (in shares) at Dec. 31, 2023 152,291      
Balance, end of period at Mar. 31, 2024 $ 1,270,357 286,163 (89,698) 1,466,822
Balance, end of period (in shares) at Mar. 31, 2024 152,450      
Balance, beginning of period at Dec. 31, 2023 $ 1,271,565 312,450 (83,015) 1,501,000
Balance, beginning of period (in shares) at Dec. 31, 2023 152,291      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income   6,002   6,002
Foreign currency translation adjustments     (6,417) (6,417)
Settlement of convertible debt conversion $ (84)     (84)
Repurchases of common stock $ (10,218)     (10,218)
Repurchases of common stock (in shares) (938)      
Termination of capped calls $ 4,381     4,381
Activity in company stock plans, net and other $ (1,302)     (1,302)
Activity in company stock plans, net and other (in shares) 698      
Share-based compensation $ 3,426     3,426
Balance, end of period at Jun. 30, 2024 $ 1,267,768 318,452 (89,432) 1,496,788
Balance, end of period (in shares) at Jun. 30, 2024 152,051      
Balance, beginning of period at Mar. 31, 2024 $ 1,270,357 286,163 (89,698) 1,466,822
Balance, beginning of period (in shares) at Mar. 31, 2024 152,450      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income   32,289   32,289
Foreign currency translation adjustments     266 266
Repurchases of common stock $ (5,186)     (5,186)
Repurchases of common stock (in shares) (475)      
Activity in company stock plans, net and other $ 769     769
Activity in company stock plans, net and other (in shares) 76      
Share-based compensation $ 1,828     1,828
Balance, end of period at Jun. 30, 2024 $ 1,267,768 $ 318,452 $ (89,432) $ 1,496,788
Balance, end of period (in shares) at Jun. 30, 2024 152,051